Trichomonas vaginalis Incidence Associated with Hormonal Contraceptive Use and HIV Infection among Women in Rakai, Uganda.

PubWeight™: 0.75‹?›

🔗 View Article (PMC 4437408)

Published in J Sex Transm Dis on March 04, 2014

Authors

Heena Brahmbhatt1, Richard Musoke2, Frederick Makumbi3, Godfrey Kigozi2, David Serwadda3, Maria Wawer4, Ronald Gray4

Author Affiliations

1: Department of Population, Reproductive and Family Health, Johns Hopkins Bloomberg School of Public Health, 615 North Wolfe Street, E4010, Baltimore, MD 21205, USA.
2: Rakai Health Science Program, P.O. Box 279, Kalisizo, Uganda.
3: Department of Statistics and Epidemiology, Makerere University, School of Public Health, New Mulago Hospital Complex, Maksph Building, P.O. Box 7072, Kampala, Uganda.
4: Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, 615 North Wolfe Street, Baltimore, MD 21205, USA.

Articles cited by this

Use of hormonal contraceptives and risk of HIV-1 transmission: a prospective cohort study. Lancet Infect Dis (2011) 10.96

Control of sexually transmitted diseases for AIDS prevention in Uganda: a randomised community trial. Rakai Project Study Group. Lancet (1999) 10.28

A systematic review of the epidemiologic interactions between classic sexually transmitted diseases and HIV: how much really is known? Sex Transm Dis (2001) 4.73

Infection with Trichomonas vaginalis increases the risk of HIV-1 acquisition. J Infect Dis (2007) 4.12

Trichomonas vaginalis infection and human immunodeficiency virus acquisition in African women. J Infect Dis (2008) 3.98

A randomized, community trial of intensive sexually transmitted disease control for AIDS prevention, Rakai, Uganda. AIDS (1998) 3.54

Sexual abstinence, contraception, and condom use by young African women: a secondary analysis of survey data. Lancet (2006) 2.77

Association between bacterial vaginosis and expression of human immunodeficiency virus type 1 RNA in the female genital tract. Clin Infect Dis (2001) 2.49

Low use of contraception among poor women in Africa: an equity issue. Bull World Health Organ (2011) 2.16

Hormonal contraceptive use, cervical ectopy, and the acquisition of cervical infections. Sex Transm Dis (2004) 2.03

Hormonal contraception and risk of sexually transmitted disease acquisition: results from a prospective study. Am J Obstet Gynecol (2001) 1.95

Trichomonas vaginalis infection: the most prevalent nonviral sexually transmitted infection receives the least public health attention. Clin Infect Dis (2006) 1.63

Trichomonas vaginalis lipophosphoglycan triggers a selective upregulation of cytokines by human female reproductive tract epithelial cells. Infect Immun (2006) 1.61

Depomedroxyprogesterone-induced hypoestrogenism and changes in vaginal flora and epithelium. Obstet Gynecol (2000) 1.50

A follow-up study of methods of contraception, sexual activity, and rates of trichomoniasis, candidiasis, and bacterial vaginosis. Am J Obstet Gynecol (1990) 1.39

Hormonal contraceptive use and female-to-male HIV transmission: a systematic review of the epidemiologic evidence. AIDS (2013) 1.33

Epidemiological synergy of Trichomonas vaginalis and HIV in Zimbabwean and South African women. Sex Transm Dis (2010) 1.29

Hormonal contraception and risk of cervical infections among HIV-1-seropositive Kenyan women. AIDS (2004) 1.11

Hormonal regulation of uterine macrophages. Dev Immunol (1998) 1.00

Use of injectable progestin contraception and risk of STI among South African women. Contraception (2009) 0.93

Determination of estrogen and androgen receptors in Trichomonas vaginalis and the effects of antihormones. Am J Obstet Gynecol (1987) 0.90

Sexually transmitted disease among women attending a family planning clinic in Zaria, Nigeria. Int J Gynaecol Obstet (1989) 0.80